It means that as a standalone oral therapy at the tested doses, it did not produce the magnitude of weight loss that pharmaceutical companies require for commercial viability
Sometimes the plateau is behavioral, not pharmacological
Additionally, there was an observation of potential improvements in dermal remodeling, a phase where the skin regains strength and elasticity, and collagen deposition, crucial for tissue repair
Heres why: Superior Bioavailability and Speed: Injections offer 100% bioavailability, meaning every microgram injected directly enters your system, bypassing any digestive hurdles
These injections might offer a minor contribution to a comprehensive weight-loss strategy, but they aren't a standalone solution
Not dramatically, not all at once, but slowly